GSK vs LEXXW · P/E 13, $103.31B cap vs rev $705.9K
GlaxoSmithKline PLC ADR (GSK) versus Lexaria Bioscience Corp (LEXXW) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. LEXXW currently screens at market cap $33.8M.
Not investment advice. Open the GSK and LEXXW stock pages for the full models.
Not investment advice.